Insider Transactions in Q3 2025 at Artiva Biotherapeutics, Inc. (RTVA)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 15
2025
|
Christopher Horan Chief Tech Operations Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,577
-4.28%
|
$7,154
$2.75 P/Share
|
|
Aug 15
2025
|
Jennifer Bush COO, CLO, Secy, Compliance Off |
SELL
Payment of exercise price or tax liability
|
Direct |
6,409
-4.07%
|
$12,818
$2.75 P/Share
|
|
Aug 15
2025
|
Neha Krishnamohan Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,813
-5.35%
|
$11,626
$2.75 P/Share
|
|
Aug 15
2025
|
Heather Raymon SVP, Research and Development |
SELL
Payment of exercise price or tax liability
|
Direct |
1,639
-3.85%
|
$3,278
$2.75 P/Share
|
|
Aug 15
2025
|
Fred Aslan President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,472
-1.16%
|
$8,944
$2.75 P/Share
|
|
Aug 15
2025
|
Fred Aslan President and CEO |
SELL
Open market or private sale
|
Direct |
25,500
-6.19%
|
$51,000
$2.73 P/Share
|